Published 15 hours ago • loading... • Updated 15 hours agoShow Less IconVertex Pharmaceuticals CFO’s case for thinking like a portfolio manager Summary by CFOAfter helping scale Vertex Pharmaceuticals from $3 billion to $13 billion in revenue, CFO and COO Charles Wagner says finance leaders must build organizations for opportunities that haven’t emerged yet.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconCFOCenterFactualityOwnershipVertex Pharmaceuticals CFO’s case for thinking like a portfolio managerAfter helping scale Vertex Pharmaceuticals from $3 billion to $13 billion in revenue, CFO and COO Charles Wagner says finance leaders must build organizations for opportunities that haven’t emerged yet.15 hours agoRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsFather's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get StartedCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated13 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageCFO broke the news 15 hours ago on Tuesday, June 16, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsCFO Plus IconFinance Plus IconBoston, Massachusetts Plus IconBusiness & Markets Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsCFO Plus IconFinance Plus IconBoston, Massachusetts Plus IconBusiness & Markets Plus IconShow All